Prognos

Prognos Health operates a data marketplace and analytics platform that provides the life sciences industry with access to harmonized, analytics-ready clinical and genomic laboratory data on over 325 million patients. The company leverages AI and machine learning to enrich this data, enabling clients to accelerate commercial strategies, target healthcare providers, and understand patient journeys in areas like oncology and rare disease. Founded in 2013, Prognos positions itself as a trusted data partner, helping pharmaceutical companies bring therapies to market faster and improve commercial execution by bypassing lengthy traditional data ingestion processes.

A managed data marketplace and analytics platform that aggregates, harmonizes, and enriches de-identified clinical and genomic laboratory data using clinically-trained AI and machine learning models. It delivers analytics-ready datasets to accelerate commercial insights for the life sciences industry.

Prognos competes in the real-world data and analytics market against large CROs and data giants (e.g., IQVIA, Flatiron Health/ Roche, Komodo Health) and other lab-data-focused companies (e.g., Tempus, Symphony Health). Its differentiation lies in its exclusive focus on curated, analytics-ready laboratory data and its direct partnerships with diagnostic labs.